Consolidated Statements of Shareholders' Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Cumulative effect of change in accounting principle	Cumulative effect of change in accounting principle Retained Earnings (Accumulated Deficit)
Balance (in shares) at Feb. 02, 2019		138,099				(782)
Balance at Feb. 02, 2019	$ (202,084)	$ 1,381	$ 742,072	$ (915,113)	$ (11,315)	$ (19,109)	$ 11,568	$ 11,568
Net income	187,176			187,176
Postretirement medical plan adjustment, net of tax	(990)				(990)
Unrealized gain (loss) on cash flow hedge, net of tax	(14,281)				(14,281)
Amounts reclassified from other comprehensive income, net of tax	0
Dividends paid	(25)		(25)
Common stock issued under stock incentive plans (in shares)		2,536
Common stock issued under stock incentive plans	0	$ 25	(25)
Common stock issued under ESPP plan (in shares)		88
Common stock issued under ESPP plan	1,729	$ 1	1,728
Stock compensation expense	18,796		18,796
Net cash received on option exercises	11,072		11,072
Treasury stock purchases (in shares)						(2,643)
Treasury stock purchases	(67,305)					$ (67,305)
Balance (in shares) at Feb. 01, 2020		140,723				(3,425)
Balance at Feb. 01, 2020	(54,344)	$ 1,407	773,618	(716,369)	(26,586)	$ (86,414)
Net income	421,030			421,030	0
Postretirement medical plan adjustment, net of tax	(33)				(33)
Unrealized gain (loss) on cash flow hedge, net of tax	10				10
Amounts reclassified from other comprehensive income, net of tax	6,081				6,081
Dividends paid	(25)		(25)
Common stock issued under stock incentive plans (in shares)		2,598
Common stock issued under stock incentive plans	0	$ 26	(26)
Common stock issued under ESPP plan (in shares)		107
Common stock issued under ESPP plan	2,676	$ 1	2,675
Stock compensation expense	32,150		32,150
Net cash received on option exercises	17,985		17,985
Treasury stock purchases (in shares)						(2,811)
Treasury stock purchases	(106,203)					$ (106,203)
Balance (in shares) at Jan. 30, 2021		143,428				(6,236)
Balance at Jan. 30, 2021	319,327	$ 1,434	826,377	(295,339)	(20,528)	$ (192,617)
Net income	426,652			426,652	0
Postretirement medical plan adjustment, net of tax	(110)				(110)
Unrealized gain (loss) on cash flow hedge, net of tax	12,417				12,417
Amounts reclassified from other comprehensive income, net of tax	9,526				9,526
Dividends paid	(25)		(25)
Common stock issued under stock incentive plans (in shares)		1,915
Common stock issued under stock incentive plans	0	$ 19	(19)
Common stock issued under ESPP plan (in shares)		108
Common stock issued under ESPP plan	3,822	$ 1	3,821
Stock compensation expense	53,837		53,837
Net cash received on option exercises	18,713		18,713
Treasury stock purchases (in shares)						(3,709)
Treasury stock purchases	(196,051)					$ (196,051)
Balance (in shares) at Jan. 29, 2022		145,451				(9,945)
Balance at Jan. 29, 2022	$ 648,108	$ 1,454	$ 902,704	$ 131,313	$ 1,305	$ (388,668)